Product Benefits

Empamet 12.5/500mg is a dual-action oral hypoglycemic medication designed for comprehensive blood glucose management. Its key benefits include:

• Dual Mechanism of Action: Combines an SGLT2 inhibitor (Empagliflozin) and a biguanide (Metformin) to lower blood sugar through multiple pathways.

• Glucose Excretion: Empagliflozin helps the kidneys remove excess glucose from the bloodstream through urine.

• Improved Insulin Sensitivity: Metformin reduces glucose production in the liver and improves the body's response to insulin.

• Cardiovascular Protection: Proven to reduce the risk of cardiovascular death and heart failure in adults with type 2 diabetes and established heart disease.

• Weight Management Support: Often associated with modest weight loss and low risk of hypoglycemia when used as directed.

• Comprehensive Control: Effectively lowers both basal (fasting) and postprandial (after-meal) blood glucose levels.